(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OPTYX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

OPTYX

ST13

US500000087597518

Class

9, 42

Filing

87597518

Registration

5997489

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

02/25/2020

Trademark type

Word

Nice classes

9, 42

Filing date

09/06/2017

Registration date

02/25/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/25/2020

Last transaction

02/25/2020

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/01/2017

First use in commerce

11/01/2017

Drawing code

4

Owner type

01

Owner location

Pound Ridge, NY

Examiner

GILLES, DEBORAH

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Kantro, Scott

Representatives

JOSEPH SOFER, ESQ. SOFER & HAROUN, LLP

Technical classification

Nice Classes

Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Computer hardware and software for managing patient populationscomputer hardware and software for managing the clinical care strategies of patients with diabetes and assisting in the clinical decision making for patients with diabetes

Class 42

Platform as service featuring information technology computer software for managing patient populationssoftware for managing the clinical care strategies of patients with diabetes and assisting in the clinical decision making for patients with diabetes

Publications

History of USPTO decisions and trademark events.

34 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

02/25/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED

01/22/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/21/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/30/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/30/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/23/2019

CNRT

NON-FINAL ACTION MAILED

09/17/2019

CNRT

SU - NON-FINAL ACTION - WRITTEN

09/17/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/06/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/06/2019

IUAF

USE AMENDMENT FILED

08/07/2019

EISU

TEAS STATEMENT OF USE RECEIVED

08/07/2019

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

02/19/2019

PUBO

PUBLISHED FOR OPPOSITION

12/25/2018

NPUB

NOTICE OF PUBLICATION

12/05/2018

ALIE

ASSIGNED TO LIE

11/16/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/02/2018

CNEA

EXAMINERS AMENDMENT MAILED

10/30/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

10/29/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/29/2018

CPRA

PRIORITY ACTION MAILED

07/25/2018

CPRA

PRIORITY ACTION WRITTEN

07/24/2018

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

07/13/2018

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

06/20/2018

NPUB

NOTICE OF PUBLICATION

06/20/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/02/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/14/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/14/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/14/2018

CNRT

NON-FINAL ACTION MAILED

11/13/2017

CNRT

NON-FINAL ACTION WRITTEN

11/13/2017

DOCK

ASSIGNED TO EXAMINER

11/06/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/12/2017

NWAP

NEW APPLICATION ENTERED

09/09/2017

Continuous trademark protection

Get notified about every new filing that threatens OPTYX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.